| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,221 |
7,616 |
$790K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,177 |
10,353 |
$733K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
677 |
677 |
$62K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
348 |
348 |
$50K |
| 99406 |
|
3,397 |
3,099 |
$45K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,473 |
2,347 |
$44K |
| 96127 |
|
9,124 |
8,180 |
$36K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
286 |
286 |
$26K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
250 |
250 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,313 |
1,307 |
$23K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
265 |
263 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,198 |
2,093 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
454 |
443 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
746 |
646 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
330 |
322 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
3,539 |
3,423 |
$14K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
306 |
306 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
99 |
99 |
$10K |
| 99385 |
|
87 |
87 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
199 |
198 |
$6K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
51 |
51 |
$5K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
251 |
242 |
$5K |
| 99215 |
Prolong outpt/office vis |
23 |
22 |
$3K |
| 90686 |
|
434 |
426 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
135 |
131 |
$2K |
| 99384 |
|
15 |
15 |
$2K |
| 99386 |
|
13 |
13 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
69 |
69 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
112 |
110 |
$2K |
| 99173 |
|
579 |
576 |
$1K |
| 99383 |
|
12 |
12 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
14 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$836.27 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
59 |
58 |
$622.40 |
| 99490 |
Ccm add 20min |
163 |
163 |
$562.51 |
| 81025 |
|
73 |
70 |
$559.93 |
| 90756 |
|
22 |
22 |
$417.46 |
| 99407 |
|
16 |
14 |
$378.77 |
| 90674 |
|
13 |
13 |
$151.91 |
| 96160 |
|
1,548 |
1,468 |
$151.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
71 |
71 |
$34.31 |
| 90651 |
|
26 |
26 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |